STOCK TITAN

Co-Diagnostics, Inc. to Host Booth at 10th Gene Quantification Event in Munich, Germany, March 20-22

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Co-Diagnostics, Inc. (NASDAQ: CODX) is set to participate in the 10th Gene Quantification Event from March 20-24, 2023, at the Technical University of Munich. Dr. Carl Wittwer, Chair of the Scientific Advisory Board, will present on 'At-Home PCR Testing for SARS-CoV-2' on March 20 at 2:00 PM. The presentation will highlight the feasibility of the Co-Dx PCR Home™ testing platform for at-home infectious disease diagnosis. This platform is under FDA review and is not yet for sale. The event will cover various topics including SARS-CoV-2 and liquid biopsy, featuring an industrial exhibition showcasing advancements in molecular diagnostics.

Positive
  • None.
Negative
  • None.

Chair of Company's SAB, Dr. Carl Wittwer, to present on at-home PCR testing

SALT LAKE CITY, March 17, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the 10th Gene Quantification Event held March 20-24 at the Technical University of Munich. Dr. Carl Wittwer, Chair of the Company's Scientific Advisory Board (SAB) will also be presenting at the event.

Dr. Wittwer's presentation, titled "At-Home PCR Testing for SARS-CoV-2," will take place at 2:00 pm local time on March 20 in Lecture Hall 15, and is expected to discuss how the Company's upcoming Co-Dx PCR Home™* testing platform makes at-home testing for infectious disease diagnosis feasible, including the multiplexing capabilities of the device. Co-Dx recently announced the initiation of clinical evaluations for this at-home/POCT real-time PCR platform, which is subject to FDA review and is not currently for sale.

The focus topics for this year's Gene Quantification Event include SARS-CoV-2, liquid biopsy and CNA, multi-omics biomarkers and more, with an Industrial Exhibition presenting the latest molecular diagnostics, qPCR, digital-PCR and NGS services to an international audience. To learn more about the event, including in-person and virtual registration details, please visit https://www.gene-quantification.de/GQ2023/.

Attendees interested in learning more about the Company and its products, including its upcoming Co-Dx PCR Home platform, are invited to visit Booth 7 in the Industrial Exhibition.

*The Co-Dx PCR Home platform is subject to U.S. Food and Drug Administration ("FDA") review and has not been cleared or approved for sale.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR Home™ platform and to locate genetic markers for use in applications other than infectious disease.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-10th-gene-quantification-event-in-munich-germany-march-20-22-301774582.html

SOURCE Co-Diagnostics

FAQ

When will Co-Diagnostics present at the Gene Quantification Event?

Co-Diagnostics will present at the Gene Quantification Event on March 20, 2023.

Who is presenting at the Gene Quantification Event for Co-Diagnostics?

Dr. Carl Wittwer, Chair of the Scientific Advisory Board, will present at the event.

What is the focus of Dr. Wittwer's presentation?

Dr. Wittwer's presentation will focus on 'At-Home PCR Testing for SARS-CoV-2'.

Is the Co-Dx PCR Home™ testing platform available for sale?

No, the Co-Dx PCR Home™ platform is currently under FDA review and not available for sale.

Where is the Gene Quantification Event being held?

The event is being held at the Technical University of Munich, Germany.

What are the dates of the Gene Quantification Event?

The event will take place from March 20-24, 2023.

Co-Diagnostics, Inc.

NASDAQ:CODX

CODX Rankings

CODX Latest News

CODX Stock Data

23.60M
29.79M
6.7%
13.96%
0.72%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SALT LAKE CITY